Market Value2,093,868,226
Total Holdings48
File Date2024-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
BCAB / BioAtla, Inc.
MLTX / MoonLake Immunotherapeutics
AMAM / Ambrx Biopharma Inc.
RYZB / RayzeBio, Inc.
AXNX / Axonics, Inc.
AMAM / Ambrx Biopharma Inc.
NMRA / Neumora Therapeutics, Inc.
VIGL / Vigil Neuroscience, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
CBAY / CymaBay Therapeutics, Inc.
NGNE / Neurogene Inc.
ALXO / ALX Oncology Holdings Inc.
ERAS / Erasca, Inc.
AVTE / Aerovate Therapeutics, Inc.
KRRO / Korro Bio, Inc.
HARP / Harpoon Therapeutics, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
RCKT / Rocket Pharmaceuticals, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
SYRE / Spyre Therapeutics, Inc.
ZNTL / Zentalis Pharmaceuticals, Inc.
IMVT / Immunovant, Inc.
IDYA / IDEAYA Biosciences, Inc.
ELVN / Enliven Therapeutics, Inc.
ACLX / Arcellx, Inc.
PRAX / Praxis Precision Medicines, Inc.
KRTX / Karuna Therapeutics, Inc.
IRON / Disc Medicine, Inc.
COGT / Cogent Biosciences, Inc.
CABA / Cabaletta Bio, Inc.
OLMA / Olema Pharmaceuticals, Inc.
IMRX / Immuneering Corporation
EDIT / Editas Medicine, Inc. Put
RYTM / Rhythm Pharmaceuticals, Inc.
GHRS / GH Research PLC
STOK / Stoke Therapeutics, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
RAPT / RAPT Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
RNA / Avidity Biosciences, Inc.
LBPH / Longboard Pharmaceuticals, Inc.
BBIO / BridgeBio Pharma, Inc.
ALPN / Alpine Immune Sciences, Inc.
APLS / Apellis Pharmaceuticals, Inc.
INSM / Insmed Incorporated
CRNX / Crinetics Pharmaceuticals, Inc.
PCVX / Vaxcyte, Inc.
EYPT / EyePoint Pharmaceuticals, Inc.
BHVN / Biohaven Ltd.
CRGX / CARGO Therapeutics, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
BMEA / Biomea Fusion, Inc.
VYNE / VYNE Therapeutics Inc.
MRNS / Marinus Pharmaceuticals, Inc.
ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
LNTH / Lantheus Holdings, Inc.
EWTX / Edgewise Therapeutics, Inc.
PHVS / Pharvaris N.V.